Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple intravenous administrations: an open-label randomised controlled trial

BACKGROUND: HX575 is a human recombinant epoetin alfa that was approved for use in Europe in 2007 under the European Medicines Agency biosimilar approval pathway. Therefore, in order to demonstrate the bioequivalence of HX575 to an existing epoetin alfa, the pharmacokinetic and pharmacodynamic respo...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Sörgel, Fritz, Thyroff-Friesinger, Ursula, Vetter, Andrea, Vens-Cappell, Bernhard, Kinzig, Martina
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2009
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2695417/
https://ncbi.nlm.nih.gov/pubmed/19463151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6904-9-10
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk